Work

Abstract A134: TROP-2-Targeted ADC DB-1305/BNT325 Demonstrates Preclinical Efficacy and Early Clinical Activity in Patients with Diffuse Pleural Mesothelioma

Year: 2025

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-25-a134

Authors: Michael Offin, Esther Redin Resano, Alvaro Q Villalonga, Charles M Rudin, Elisa Destanchina, Dennis Kinyua, Erika Hamilton, Aaron Lisberg, Nashat Gabrail, Alexander Spira, Melissa Johnson, Yang Qiu, Rick Chu, Zhongyuan Zhu, Xiaodong Sun, Zhongwei Jia, Bin Zhang, Hua Mu

Institutions: Memorial Sloan Kettering Cancer Center, Sarah Cannon, University of California, Los Angeles, Gabrail Cancer Center, Duality Biotherapeutics, Inc. (China)

Language: English

Topic: Occupational and environmental lung diseases

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415444372

Cites:

Cited by:

Related to: